BX Swiss - USA
285,59
|
1,18
|
0,41%
|
Analysen zu BX Swiss - USA-Werten
07.02.25 | Amazon Kaufen | DZ BANK | |
07.02.25 | Amazon Overweight | Barclays Capital | |
07.02.25 | Amazon Buy | Jefferies & Company Inc. | |
07.02.25 | Amazon Outperform | RBC Capital Markets | |
07.02.25 | Amazon Overweight | JP Morgan Chase & Co. | |
07.02.25 | Amazon Buy | Goldman Sachs Group Inc. | |
07.02.25 | Amazon Buy | Goldman Sachs Group Inc. | |
07.02.25 | Amazon Buy | UBS AG | |
06.02.25 | Nike Neutral | UBS AG | |
06.02.25 | Nike Neutral | JP Morgan Chase & Co. | |
06.02.25 | Nike Sector Perform | RBC Capital Markets | |
06.02.25 | Intel Verkaufen | DZ BANK | |
06.02.25 | Coca-Cola Outperform | RBC Capital Markets | |
05.02.25 | Pfizer Kaufen | DZ BANK | |
05.02.25 | Alphabet A Neutral | UBS AG | |
05.02.25 | Alphabet A Outperform | RBC Capital Markets | |
05.02.25 | Alphabet A Buy | Jefferies & Company Inc. | |
05.02.25 | Pfizer Buy | Goldman Sachs Group Inc. | |
05.02.25 | Pfizer Neutral | UBS AG | |
05.02.25 | Pfizer Neutral | JP Morgan Chase & Co. | |
05.02.25 | Alphabet A Overweight | JP Morgan Chase & Co. | |
05.02.25 | Alphabet A Buy | Goldman Sachs Group Inc. | |
05.02.25 | Alphabet A Neutral | UBS AG | |
04.02.25 | Pfizer Buy | Jefferies & Company Inc. | |
04.02.25 | Boeing Buy | UBS AG | |
04.02.25 | Pfizer Neutral | UBS AG | |
04.02.25 | Pfizer Neutral | JP Morgan Chase & Co. | |
04.02.25 | Intel Neutral | UBS AG | |
04.02.25 | Apple Neutral | UBS AG | |
03.02.25 | Coca-Cola Buy | UBS AG | |
31.01.25 | Visa Outperform | RBC Capital Markets | |
31.01.25 | Visa Kaufen | DZ BANK | |
31.01.25 | Meta Platforms Kaufen | DZ BANK | |
31.01.25 | Boeing Kaufen | DZ BANK | |
31.01.25 | Intel Sell | Goldman Sachs Group Inc. | |
31.01.25 | Apple Halten | DZ BANK | |
31.01.25 | Apple Underperform | Jefferies & Company Inc. | |
31.01.25 | Intel Neutral | UBS AG | |
31.01.25 | Visa Buy | UBS AG | |
31.01.25 | Intel Underweight | JP Morgan Chase & Co. |